Intensive insulin therapy and starch (HES 200/0.5) had some risk and no clear benefit in severe sepsis
- PMID: 18588255
- DOI: 10.7326/0003-4819-148-12-200806170-02004
Intensive insulin therapy and starch (HES 200/0.5) had some risk and no clear benefit in severe sepsis
Comment on
-
Intensive insulin therapy and pentastarch resuscitation in severe sepsis.N Engl J Med. 2008 Jan 10;358(2):125-39. doi: 10.1056/NEJMoa070716. N Engl J Med. 2008. PMID: 18184958 Clinical Trial.
Similar articles
-
Hydroxyethyl starch in sepsis.Dan Med J. 2014 Jan;61(1):B4764. Dan Med J. 2014. PMID: 24393593 Clinical Trial.
-
Intensive insulin therapy and pentastarch resuscitation in severe sepsis.N Engl J Med. 2008 Jan 10;358(2):125-39. doi: 10.1056/NEJMoa070716. N Engl J Med. 2008. PMID: 18184958 Clinical Trial.
-
[The study of hypertonic saline and hydroxyethyl starch treating severe sepsis].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Mar;23(3):150-3. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011. PMID: 21366943 Clinical Trial. Chinese.
-
Hydroxyethyl starch for resuscitation.Curr Opin Crit Care. 2013 Aug;19(4):321-5. doi: 10.1097/MCC.0b013e3283632de6. Curr Opin Crit Care. 2013. PMID: 23743591 Review.
-
Fluid therapy in critical illness: a special focus on indication, the use of hydroxyethyl starch and its different raw materials.Curr Opin Anaesthesiol. 2013 Jun;26(3):253-60. doi: 10.1097/ACO.0b013e3283606b71. Curr Opin Anaesthesiol. 2013. PMID: 23492982 Review.
Cited by
-
Analysis of alternatives for insulinizing patients to achieve glycemic control and avoid accompanying risks of hypoglycemia.Biomed Rep. 2015 May;3(3):284-288. doi: 10.3892/br.2015.434. Epub 2015 Feb 19. Biomed Rep. 2015. PMID: 26137223 Free PMC article.
-
Hyperglycemia increases the complicated infection and mortality rates during induction therapy in adult acute leukemia patients.Rev Bras Hematol Hemoter. 2013;35(1):39-43. doi: 10.5581/1516-8484.20130013. Rev Bras Hematol Hemoter. 2013. PMID: 23580883 Free PMC article.